ASCL1 and neoplasm: In all these tumours, manipulating ASCL1 activity could alter the balance between a proliferating progenitor tumour cell identity, usually associated with a poorer prognosis, and that of a more differentiated cell type where prognosis may be better [12–14, 28, 54–57].